Recent HIV infections and estimated HIV incidence among adolescents from key populations

被引:0
|
作者
Zeballos, Diana [1 ]
Soares, Fabiane [1 ]
Magno, Laio [1 ,2 ]
Szwarcwald, Celia Landmann [3 ]
Ferreira, Orlando [4 ]
Westin, Mateus [5 ]
Greco, Dirceu [5 ]
Grangeiro, Alexandre [6 ]
Dourado, Ines [1 ]
机构
[1] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil
[2] Univ Estado Bahia, Dept Ciencias Vida, Salvador, BA, Brazil
[3] Fundacao Oswaldo Cruz, Inst Comun & Informacao Cient & Tecnol Saude, Rio De Janeiro, RJ, Brazil
[4] Univ Fed Rio Janeiro, Lab Virol Mol, Inst Biol, Rio De Janeiro, RJ, Brazil
[5] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil
[6] Univ Sao Paulo, Fac Med, Sao Paulo, SP, Brazil
来源
REVISTA DE SAUDE PUBLICA | 2024年 / 58卷
关键词
Adolescent; Sexual and Gender Minorities; HIV infections;
D O I
10.11606/s1518-8787.2020054005997
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJETIVE: To identify recent HIV-1 infection and estimate HIV incidence among adolescent men who have sex with men (AMSM) and transgender women (ATGW) in Brazil. METHODS: From January to December 2020, a cross-sectional analysis was conducted with baseline data from the PrEP1519 study, an HIV pre-exposure prophylaxis (PrEP) demonstration cohort in Brazil among sexually active AMSM/ATGW aged 15-19. For enrollment, participants were screened with a fourth-generation HIV rapid test. The recent infection testing algorithm (RITA) included a recency assay in blood specimens, viral load, and CD4 cell count prior to antiretroviral treatment use. Among these participants, RITA-based HIV incidence was estimated using a mean duration of recency infection of 214 days and a false-recent rate of 0.02. RESULTS: Out of the 494 participants screened, 21 tested positive for HIV. Following RITA, five adolescents had a recent HIV infection, 14 had long-term infections, and two did not have blood specimens available. We classified these two participants as long-term infection cases due to CD4 cell counts and previous use of antiretroviral treatment. Among those who tested positive, all but one were AMSM (94.7%), 73.6% were aged 18-19, and 76.2% were non-White. The HIV prevalence was 4.2%, and the estimated HIV incidence was 1.7%. CONCLUSIONS: The estimated incidence highlights the need for targeted HIV prevention interventions, such as PrEP, for sexual minority adolescents. Integrating RITA into routine HIV testing services for this population provides valuable information on the current HIV epidemic. This strategy can aid in monitoring the effectiveness of prevention efforts and improving early entry to HIV care.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection
    Traeger, Michael W.
    Cornelisse, Vincent J.
    Asselin, Jason
    Price, Brian
    Roth, Norman J.
    Willcox, Jeff
    Tee, Ban Kiem
    Fairley, Christopher K.
    Chang, Christina C.
    Armishaw, Jude
    Vujovic, Olga
    Penn, Matthew
    Cundill, Pauline
    Forgan-Smith, George
    Gall, John
    Pickett, Claire
    Mak, Anne
    Spelman, Tim D.
    Long Nguyen
    Murphy, Dean A.
    Ryan, Kathleen E.
    El-Hayek, Carol
    West, Michael
    Ruth, Simon
    Batrouney, Colin
    Lockwood, John T.
    Hoy, Jennifer F.
    Hellard, Margaret E.
    Stoove, Mark A.
    Wright, Edwina J.
    de Wit, John
    Lal, Luxi
    Audsley, Jennifer
    Duncan, Alison
    Sasadeusz, Joe
    Allan, Brent
    Whelan, Michael
    McPhail, Daniel
    Wilson, David
    Holt, Martin
    Williams, Chris
    Wesselingh, Steve
    Ward, James
    Gallant, Danny
    Ward, Alison
    Chong, Alistair
    McKinnon, Katharine
    Aguirre, Ivette
    Read, Timothy
    Moore, Richard
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (14): : 1380 - 1390
  • [42] Testing bias in calculating HIV incidence from the Serologic Testing Algorithm for Recent HIV Seroconversion
    Remis, Robert S.
    Palmer, Robert W. H.
    AIDS, 2009, 23 (04) : 493 - 503
  • [43] Estimated HIV Incidence in California, 2006-2009
    Scheer, Susan
    Nakelsky, Shoshanna
    Bingham, Trista
    Damesyn, Mark
    Sun, Dan
    Chin, Chi-Sheng
    Buckman, Anthony
    Mark, Karen E.
    PLOS ONE, 2013, 8 (02):
  • [44] The cascade of HIV care among key populations in Indonesia: a prospective cohort study
    Januraga, Pande Putu
    Reekie, Joanne
    Mulyani, Tri
    Lestari, Bony Wiem
    Iskandar, Shelly
    Wisaksana, Rudi
    Kusmayanti, Nur Aini
    Subronto, Yanri Wijayanti
    Widyanthini, Desak Nyoman
    Wirawan, Dewa Nyoman
    Wongso, Lydia Verina
    Sudewo, Anindita Gabriella
    Sukmaningrum, Evi
    Nisa, Tiara
    Prabowo, Bagus Rahmat
    Law, Matthew
    Cooper, David A.
    Kaldor, John M.
    LANCET HIV, 2018, 5 (10): : E560 - E568
  • [45] Why a special issue of JIDC on tuberculosis and HIV among key populations in Ukraine?
    Klepikov, Andriy
    Basenko, Anton
    Lyashko, Viktor
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2019, 13 (07): : 81S - 82S
  • [46] The application of new metrics for understanding trends in undiagnosed HIV among key populations
    Gray, Richard T.
    Camara, Hawa
    Khawar, Laila
    Grulich, Andrew
    Guy, Rebecca
    McGregor, Skye
    Medland, Nicholas
    AIDS, 2023, 37 (12) : 1851 - 1859
  • [47] HTLV AND HIV CO-INFECTION AMONG KEY POPULATIONS, DOMINICAN REPUBLIC
    Paulino-Ramirez, Robert
    Charow, Rebecca
    DePena, Xelenia
    Rosario, Luis
    Rosa, Jorge
    Rosa, Rosana
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 357 - 357
  • [48] Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya
    Mutisya, Elizabeth Mueni
    Muturi-Kioi, Vincent
    Abaasa, Andrew
    Nyasani, Delvin
    Kabuti, Rhoda W.
    Lunani, Laura
    Kotikot, Timothy
    Mundia, Moses
    Mutua, Gaudensia
    Ombati, Geoffrey
    Nduta, Hannah
    Price, Matt A.
    Kimani, Joshua
    Anzala, Aggrey Omu
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [49] Perspectives on HIV Self-Testing Among Key and Affected Populations in Kenya
    Sircar, Neiloy R.
    Maleche, Allan A.
    AFRICAN HEALTH SCIENCES, 2022, 22 (02) : 37 - 45
  • [50] Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya
    Elizabeth Mueni Mutisya
    Vincent Muturi-Kioi
    Andrew Abaasa
    Delvin Nyasani
    Rhoda W. Kabuti
    Laura Lunani
    Timothy Kotikot
    Moses Mundia
    Gaudensia Mutua
    Geoffrey Ombati
    Hannah Nduta
    Matt A. Price
    Joshua Kimani
    Aggrey Omu Anzala
    BMC Public Health, 22